AcquisitionOther
Singular Genomics Systems, Inc. acquired target
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
Singular Genomics Systems, Inc. -> target · $20.00
The commercially available G4 ® Sequencing Platform is a powerful, highly versatile benchtop genomic sequencer designed to produce fast and accurate results.
Open source record (SEC) ↗